A beaten-down biotech just lost a meaningful backer — should you care?
19/5 23:53
Key PointsSold 237,103 shares; estimated trade size $7.77 million (based on average closing price from January to March 2026)...
|
|
|
19/5 23:53
Key PointsSold 237,103 shares; estimated trade size $7.77 million (based on average closing price from January to March 2026)...